NCT04267809View on ClinicalTrials.gov

Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 22, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Endoplasmic Reticulum StressViral InfectionYellow Fever
Interventions
DRUG

Metformin Hydrochloride

Metformin 500mg tablets are registered and licensed in Singapore. For the study, we will be sourcing the Metformin tablets from Singapore General Hospital Formulary.

DRUG

Calcium and Vitamin D

Calcium and Vitamin D tablets are registered and licensed in Singapore. For the study, we will be sourcing the Calcium and Vitamin D tablets from Singapore General Hospital Formulary.

Trial Locations (1)

169608

Singhealth Investigational Medicine Unit, Singapore

All Listed Sponsors
collaborator

Duke-NUS Graduate Medical School

OTHER

lead

Singapore General Hospital

OTHER

NCT04267809 - Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection | Biotech Hunter | Biotech Hunter